Furthermore, our results with a large-scale validation of SCD1 protein expression in patient-derived ovarian cancer tissues emphasize the need for further investigations into SCD1 inhibitors as potential treatment options for ovarian cancer therapy. Here, SCD is linked to ovarian carcinoma.